rolipram has been researched along with Cancer of Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kowalczyk, P | 1 |
| Kinjo, T | 1 |
| Kowalczyk, M | 1 |
| Walaszek, Z | 1 |
| Hanausek, M | 1 |
| Slaga, TJ | 1 |
| Marko, D | 1 |
| Romanakis, K | 1 |
| Zankl, H | 1 |
| Fürstenberger, G | 1 |
| Steinbauer, B | 1 |
| Eisenbrand, G | 1 |
2 other studies available for rolipram and Cancer of Skin
| Article | Year |
|---|---|
Effect of phosphodiesterase antagonists on glucocorticoid mediated growth inhibition in murine skin cell lines.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Dos | 2009 |
Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Carcinoma; Cell Cycle; Cell Division; Cell Si | 1998 |